Ascorbate sensitizes human osteosarcoma cells to the cytostatic effects of cisplatin

Osteosarcoma (OS) is the most common malignant bone tumor and a leading cause of cancer‐related deaths in children and adolescents. Current standard treatments for OS are a combination of preoperative chemotherapy, surgical resection, and adjuvant chemotherapy. Cisplatin is used as the standard chem...

Descripción completa

Detalles Bibliográficos
Autores principales: Oka, Naohiro, Komuro, Akiyoshi, Amano, Hisayuki, Dash, Suman, Honda, Masahiko, Ota, Kazushige, Nishimura, Shunji, Ueda, Takeshi, Akagi, Masao, Okada, Hitoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387887/
https://www.ncbi.nlm.nih.gov/pubmed/32725721
http://dx.doi.org/10.1002/prp2.632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387887/
https://www.ncbi.nlm.nih.gov/pubmed/32725721
http://dx.doi.org/10.1002/prp2.632

Ejemplares similares